Literature DB >> 22992246

[Summary of the Dutch College of General Practitioners' practice guideline 'Depression'].

Mariëlle J P van Avendonk1, Evelyn M van Weel-Baumgarten, Gerda M van der Weele, Tjerk Wiersma, Jako S Burgers.   

Abstract

This guideline gives recommendations for the management of depression and depressive symptoms. The diagnosis of suspected depression requires a broad exploration of symptoms, sometimes over several visits. The guideline promotes self-management and patient empowerment during the healing process. The initial step in the treatment of depressive symptoms is patient education; patients with depression are supported with activity scheduling and are offered a short course of psychological treatment. If the initial treatment in patients with depression is not effective or if the depression is associated with severe suffering, severe social dysfunctioning or severe psychiatric comorbidity, psychotherapy or an antidepressant is recommended.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992246

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Effectiveness of a tailored implementation programme to improve recognition, diagnosis and treatment of anxiety and depression in general practice: a cluster randomised controlled trial.

Authors:  Henny Sinnema; Maria Cristina Majo; Daniëlle Volker; Adriaan Hoogendoorn; Berend Terluin; Michel Wensing; Anton van Balkom
Journal:  Implement Sci       Date:  2015-03-12       Impact factor: 7.327

2.  Elusive search for effective provider interventions: a systematic review of provider interventions to increase adherence to evidence-based treatment for depression.

Authors:  Eric R Pedersen; Lisa Rubenstein; Ryan Kandrack; Marjorie Danz; Bradley Belsher; Aneesa Motala; Marika Booth; Jody Larkin; Susanne Hempel
Journal:  Implement Sci       Date:  2018-07-20       Impact factor: 7.327

3.  Factors contributing to the recognition of anxiety and depression in general practice.

Authors:  Henny Sinnema; Berend Terluin; Daniëlle Volker; Michel Wensing; Anton van Balkom
Journal:  BMC Fam Pract       Date:  2018-06-23       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.